Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;37(1):45-53.
doi: 10.1111/liv.13186. Epub 2016 Jun 30.

The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment

Amr Kandeel  1 , Mohamad Genedy  1 , Samir El-Refai  1 , Anna L Funk  2 , Arnaud Fontanet  2   3 , Maha Talaat  4   5
Affiliations

The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment

Amr Kandeel et al. Liver Int. 2017 Jan.

Abstract

Background & aims: In 2015, a national Egyptian health issue survey was conducted to describe the prevalence of hepatitis C virus (HCV) infection. In this paper, we describe the HCV burden in 2015, compare the results with the national survey conducted in 2008, and discuss the implications of the new findings on prevention of HCV in Egypt.

Methods: A multistage probability sampling approach was used, similar to the national demographic survey conducted in 2008. More than 90% of sampled individuals complied with the interview and provided blood samples.

Results: In the 15-59-year age groups, the prevalence of HCV antibody was found to be 10.0% (95% CI 9.5-10.5) and that of HCV RNA to be 7.0% (95% CI 6.6-7.4). In children, 1-14 years old, the prevalence of HCV antibody and HCV RNA were 0.4% (95% CI 0.3-0.5) and 0.2% (95% CI 0.1-0.3) respectively. Approximately, 3.7 million persons have chronic HCV infection in the age group 15-59 in 2015. An estimated 29% reduction in HCV RNA prevalence has been seen since 2008, which is largely attributable to the ageing of the group infected 40-50 years ago during the mass schistosomiasis treatment campaigns. Prevention efforts may have also contributed to this decline, with an estimated 75% (95% CI 6-45) decrease in HCV incidence in the 0-19 year age groups over the past 20 years.

Conclusions: These findings can be used to shape future HCV prevention policies in Egypt.

Keywords: hepatitis C Egypt; incidence HCV; nation-wide surveys; prevalence HCV.

PubMed Disclaimer

Conflict of interest statement

The authors do not have any disclosures to report.

Figures

Figure 1
Figure 1
(A) Age‐specific prevalence of hepatitis C virus (HCV) antibody‐positive persons in 2008 and 2015 (left), then shifted (by 7 years) 2008 and 2015 (right). (B) Age‐specific prevalence of HCV RNA‐positive persons in 2008 and 2015 (left), then shifted (by 7 years) 2008 and 2015 (right).
Figure 2
Figure 2
Prevalence of hepatitis C virus antibody in the 2008 and 2015 Egyptian Demographic and Health Surveys.
See this image and copyright information in PMC

References

    1. Gower E, Estes C, Blach S, Razavi‐Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61: S45–57. - PubMed
    1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age‐specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333–42. - PubMed
    1. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529–38. - PubMed
    1. El‐Zanaty F, Way A. (2009). Egypt Demographic and Health Survey 2008. Cairo, Egypt: Ministry of Health,El‐Zanaty and Associates, and Macro International.
    1. Ministry of Health, Egypt , El‐Zanaty and Associates , Egypt and ICF International . (2015). Egypt Health Issues Survey 2015. Cairo, Egypt and Rockville, MD: Ministry of Health and ICF International.